A once-nightly oral pill helped control obstructive sleep apnea in a large, Phase III clinical trial presented at the 2026 ...

New research shows Ozempic may reduce sleep apnea severity by over 50%. Here’s what the science actually says.

New research shows GLP-1 drugs like Ozempic may reduce sleep apnea severity — here's what the latest science says ...

Could Ozempic replace your CPAP? New research on GLP-1 drugs and sleep apnea has doctors paying attention.

Researchers recently tested a medicine called AD109 in a large phase 3 clinical trial and found encouraging results. The ...

Home Sleep Apnea Testing Devices Market · GlobeNewswire Inc. Dublin, May 20, 2026 (GLOBE NEWSWIRE) -- The "Home Sleep Apnea Testing Devices - Global Strategic Business Report" has been added to ...

Tirzepatide GLP-1 medication is known to improve sleep apnea for people with both obstructive sleep apnea (OSA) and obesity, ...

ResMed (RMD) is in focus after announcing a collaboration with Oura that connects Oura Ring users in the US to ResMed’s sleep education tools, assessments, and potential care pathways for obstructive ...

A once-nightly oral pill helped control obstructive sleep apnea in a large, phase 3 clinical trial presented at the 2026 ATS International Conference.

Recently diagnosed with obstructive sleep apnea? Learn how continuous positive airway pressure, automatic positive airway ...

May 18 (Reuters) - Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main goal in a late-stage trial, potentially offering a convenient alternative ...

Having both OSA and insomnia makes treatment more complex. Learn why addressing both is critical for heart health and how CBTi can help you stick to CPAP.